AbbVie, active in the pharmaceutical sector, won first place in the Italy Pharma RepTrak® 2018 ranking for the second consecutive year, drawn up by the Reputation Institute, an international leader in measuring the reputation of over 7 thousand companies worldwide.
AbbVie achieved a score of 72,3 points corresponding to the "strong" reputational band, with excellent results also in the bands: quality products and services, innovation, work environment, governance understood in terms of correctness and transparency, social and environmental responsibility , leadership, performance.
“The confirmation for the second consecutive year of AbbVie as a company in the pharmaceutical sector with the best reputation in Italy represents for us an extremely important result, which spurs us to maintain and strengthen our priority commitment in research and development activities, where more than 8.800 of the company's people work worldwide, with ongoing studies in more than 70 countries. In the oncology area alone, there are over 125 clinical studies conducted by AbbVie involving research on 42 new drugs and new indications” comments Fabrizio Greco, CEO of AbbVie Italy.
